Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions

被引：15
|
作者：
Cesinaro, AM
Natoli, C
Grassadonia, A
Tinari, N
Iacobelli, S
Trentini, GP
机构：
[1] Univ Modena & Reggio Emilia, Sect Pathol Anat, Dept Morphol Sci & Legal Med, Modena, Italy
[2] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
10.1046/j.1523-1747.2002.17642.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [31] Mutations of the BRAF gene in benign and malignant melanocytic lesions
    Yazdi, AS
    Palmedo, G
    Flaig, MJ
    Puchta, U
    Reckwerth, A
    Rütten, A
    Mentzel, T
    Hügel, H
    Hantschke, M
    Schmid-Wendtner, MH
    Kutzner, H
    Sander, CA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1160 - 1162
  • [32] MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions
    van Ipenburg, Jolique A.
    Gillis, Ad J. M.
    Dorssers, Lambert C. J.
    Van den Bosch, Quincy C. C.
    van Ginderdeuren, Rita
    Missotten, Guy S.
    Naus, Nicole
    Paridaens, Dion
    Looijenga, Leendert H. J.
    Verdijk, Robert M.
    OPHTHALMOLOGY, 2020, 127 (03) : 432 - 434
  • [33] ULTRASTRUCTURAL FEATURES OF BENIGN AND MALIGNANT LESIONS OF MELANOCYTIC NATURE
    FILIPPOVA, NA
    SHCETININA, LN
    ARKHIV PATOLOGII, 1992, 54 (02) : 39 - 45
  • [34] Expression of the tumor suppressor gene product p16(INK4) in benign and malignant melanocytic lesions
    KellerMelchior, R
    Piepkorn, MW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 288 - 288
  • [35] Expression of topoisomerase II alpha (Topo II) in benign and malignant melanocytic lesions.
    Mu, XC
    Jones, DM
    Tran, TA
    Ross, JS
    Carlson, JA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 61A - 61A
  • [36] Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival
    Strizzi, L
    Muraro, R
    Vianale, G
    Natoli, C
    Talone, L
    Catalano, A
    Mutti, L
    Tassi, G
    JOURNAL OF PATHOLOGY, 2002, 197 (02): : 218 - 223
  • [37] INTERLEUKIN-2 RECEPTOR EXPRESSION IN BENIGN AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    KERNOHAN, NM
    SEWELL, HF
    JOURNAL OF PATHOLOGY, 1988, 155 (04): : A353 - A353
  • [38] MSG1 expression in benign and malignant Melanocytic lesions of skin and mucosa.
    Sedghizadeh, PP
    Williams, JD
    Allen, CM
    de la Chapelle, A
    Prasad, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (03) : 471 - 471
  • [39] MOLECULAR CHANGES ASSOCIATED WITH HUMAN MALIGNANT MELANOMAS: EXPRESSION OF NESTIN, C-MYC, PDGF, bFGF IN BENIGN AND MALIGNANT MELANOCYTIC LESIONS
    Fiuraskova, Michala
    Btychtova, Svetlana
    Hlobilkova, Alice
    Ehrmann, Jiri, Jr.
    Tichy, Martin, Jr.
    Kolar, Zdenek
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3487 - 3488
  • [40] MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium
    Sedghizadeh, PP
    Williams, JD
    Allen, CM
    Prasad, ML
    MEDICAL SCIENCE MONITOR, 2005, 11 (07): : BR189 - BR194
12345